125 related articles for article (PubMed ID: 7373947)
1. BCG immunotherapy of lung cancer.
Holmes EC
Jpn J Surg; 1980 Mar; 10(1):1-6. PubMed ID: 7373947
[TBL] [Abstract][Full Text] [Related]
2. Intralesional injection of BCG using the fibreoptic bronchoscope in the treatment of bronchogenic carcinoma.
Millar JW; Hunter AM; Wightman AJ; Horne NW
Eur J Respir Dis; 1980 Jun; 61(3):162-6. PubMed ID: 7439279
[TBL] [Abstract][Full Text] [Related]
3. Intralesional BCG immunotherapy of pulmonary tumors.
Holmes EC; Ramming KP; Bein ME; Coulson WF; Callery CD
J Thorac Cardiovasc Surg; 1979 Mar; 77(3):362-8. PubMed ID: 762979
[TBL] [Abstract][Full Text] [Related]
4. Intralesional BCG injection of pulmonary neoplasms: radiographic findings.
Fon GT; Bein ME; Holmes EC; Huberman RP
AJR Am J Roentgenol; 1981 Aug; 137(2):269-75. PubMed ID: 6789633
[TBL] [Abstract][Full Text] [Related]
5. Five-year results of a controlled study of BCG immunotherapy after surgical resection in bronchogenic carcinoma.
Millar JW; Roscoe P; Pearce SJ; Ludgate S; Horne NW
Thorax; 1982 Jan; 37(1):57-60. PubMed ID: 7041323
[TBL] [Abstract][Full Text] [Related]
6. In vitro differences in lymphocyte subpopulation reactivity in lung cancer patients: purified protein derivative-specific suppressor T lymphocytes in patients who have received Bacillus Calmette-Guerin.
Ostenson RC; Lum LG
Clin Immunol Immunopathol; 1984 Feb; 30(2):233-40. PubMed ID: 6198118
[TBL] [Abstract][Full Text] [Related]
7. Survival of patients with bronchogenic carcinoma modified by BCG immunotherapy.
Warren SE; Crispen RG; Nika B
Am Surg; 1978 Jul; 44(7):428-31. PubMed ID: 686527
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of cancer patients with Bacillus Calmette-Guérin: summary of four years of experience in Japan.
Torisu M; Fukawa M; Nishimura M; Harasaki H; Kai S; Tanaka J
Ann N Y Acad Sci; 1976; 277(00):160-86. PubMed ID: 1069547
[TBL] [Abstract][Full Text] [Related]
9. Surgery, BCG immunotherapy, and multichemotherapy in T3 stage-3 bronchogenic carcinoma.
Rioseco A
Chest; 1981 Feb; 79(2):176-85. PubMed ID: 7460649
[TBL] [Abstract][Full Text] [Related]
10. Aerosolized BCG (Tice strain) treatment of bronchogenic carcinoma: phase I study.
Cusumano CL; Jernigan JA; Waldman RH
J Natl Cancer Inst; 1975 Aug; 55(2):275-9. PubMed ID: 169370
[TBL] [Abstract][Full Text] [Related]
11. BCG, levamisole and transfer factor in the treatment of cancer.
Spitler LE
Prog Exp Tumor Res; 1980; 25():178-92. PubMed ID: 6986631
[No Abstract] [Full Text] [Related]
12. Chemoimmunotherapy of small cell bronchogenic carcinoma.
Holoye PY; Samuels ML; Smith T; Sinkovics JG
Cancer; 1978 Jul; 42(1):34-40. PubMed ID: 208755
[TBL] [Abstract][Full Text] [Related]
13. The predictive value of purified protein derivative results on complications and prognosis in patients with bladder cancer treated with bacillus Calmette-Guerin.
Bilen CY; Inci K; Erkan I; Ozen H
J Urol; 2003 May; 169(5):1702-5. PubMed ID: 12686812
[TBL] [Abstract][Full Text] [Related]
14. BCG immunostimulation in primary pulmonary cancer (a clinical, immunological and radiological study).
Dénes L; Büttner K; Galambos G; Krasznai G
Dev Biol Stand; 1986; 58 ( Pt A)():425-32. PubMed ID: 3297874
[TBL] [Abstract][Full Text] [Related]
15. Effect of systemic administration of BCG cell walls on bronchogenic carcinoma in hamsters.
Zwilling BS; Springer ST; Kaufman DG
J Natl Cancer Inst; 1977 May; 58(5):1473-7. PubMed ID: 323508
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma.
Jansen HM; The TH; Orie NG
Thorax; 1980 Oct; 35(10):781-7. PubMed ID: 7466726
[TBL] [Abstract][Full Text] [Related]
17. Chemo-immunotherapy for unresectable bronchogenic carcinoma.
Sarna GP; Lowitz BB; Haskell CM; Dorey FJ; Cline MJ
Cancer Treat Rep; 1978 May; 62(5):681-7. PubMed ID: 350397
[TBL] [Abstract][Full Text] [Related]
18. Autologous x-irradiated tumour cells and percutaneous BCG in operable lung cancer.
Stack BH; McSwan N; Stirling JM; Hole DJ; Spilg WG; McHattie I; Elliott JA; Gillis CR; Turner MA; White RG
Thorax; 1982 Aug; 37(8):588-93. PubMed ID: 7179188
[TBL] [Abstract][Full Text] [Related]
19. Cellular immune reactions in patients with bronchogenic carcinoma before and after radio-, chemo- and immunotherapy.
Gropp C; Havemann K
Z Immunitatsforsch Immunobiol; 1977 Sep; 153(3):236-47. PubMed ID: 930234
[No Abstract] [Full Text] [Related]
20. Adjuvant immunotherapy in bronchogenic carcinoma.
Takita H; Minowada J; Han T; Takada M; Lane WW
Ann N Y Acad Sci; 1976; 277(00):345-54. PubMed ID: 1069554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
